Meeting
2019 ASCO Annual Meeting
IMRT pelvic radiotherapy with simultaneous integrated boost in high-risk prostate cancer: Results after 10 years.
Authors
Christian Ekanger
Kreftavdelingen, Haukeland Universitetssjukehus, Bergen, Norway, Bergen, Norway
Christian Ekanger , Olav Dahl
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary (Prostate) Cancer
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Prostate Cancer–Local-Regional Disease
Citation
J Clin Oncol 37, 2019 (suppl; abstr 5084)
DOI
10.1200/JCO.2019.37.15_suppl.5084
Abstract #
5084
Poster Bd #
196
Abstract Disclosures
Similar Posters
Poster
2014 Genitourinary Cancers Symposium
Long-term clinical and toxicity outcomes of hypofractionated intensity-modulated radiation therapy for clinically localized prostate cancer.
First Author: Rupesh Kotecha
Poster
2024 ASCO Genitourinary Cancers Symposium
Long-term treatment outcomes from the International Multi-Institutional Stereotactic Body Radiation Therapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium.
First Author: Luca Faustino Valle
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Comparison of liver-directed combined radiotherapy versus sorafenib in patients with locally advanced hepatocellular carcinoma with portal vein tumor thrombosis: An Asian Liver Radiotherapy Group Study.
First Author: Jinsil Seong
Poster
2022 ASCO Genitourinary Cancers Symposium
Radiation technique and outcomes following moderately hypofractionated treatment of low risk prostate cancer: A secondary analysis of the NRG oncology RTOG 0415 randomized clinical trial.
First Author: David James Carpenter